Polymerase Chain Reaction (PCR) Technologies Market 2022-2028
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
発行: Orion Market Research
ページ情報: 英文 125 Pages
Global Polymerase Chain Reaction (PCR) Technologies Market Size, Share & Trends Analysis Report by Test Application (Research, Clinical Diagnostics, Forensic and Other (environmental microbiology)) By-Products (Instruments, Reagents and Consumables and Software) By End-User (Pharmaceutical and Biotechnology Industries, Clinical Diagnostics Labs and Hospitals and Academic and Research Organizations) Forecast 2022-2028
The global polymerase chain reaction (pcr) technologies market is anticipated to grow at a favorable CAGR of around 5.7% during the forecast period. the growth of the market is mainly driven by, technological advancements and growing demand for innovative devices have lead to the introduction of miniaturization of the devices in the market. The introduction of innovative devices by the key market players is anticipated to drive the global market during the forecast period. For instance, in February 2022, QuantuMDx Group, a UK-based diagnostics company has developed Point of Need molecular diagnostics. Point of Need(PoN0 PCR testing provides results within minutes and does not require laboratory skills or specialist training. QuantuMDx's SARS-CoV-2 assay is used along with the proprietary Q-POC device and can be used at any location, by anyone, with minimal training. It provides lab-quality PCR test results in just 30 minutes.
Additionally, polymerase chain reaction technologies are proven to be one of the most important, and widely used techniques in modern biology. Moreover, the advantage of advanced PCR over traditional PCR technology such as real-time polymerase chain reaction(RT PCR), is expected to fuel their adoption among end-user industries such as pharmaceutical and biotechnology industries, clinical diagnostics labs, and hospitals and others.
The global polymerase chain reaction (PCR) technologies market is segmented on the basis of application, product, and end-user. Based on application, the market is segmented into research application, clinical diagnostics application, forensic application, and other application. Based on products, the market is bifurcated into instruments, reagents and consumables, and software. PCR instruments include standard PCR system, digital PCR system, and RT PCR system. Based on end-user, the market is segmented into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals and academic research organization. Based on the product, the digital PCR system segment is projected to rise during the forecast period. The rising incidence of a genetic disorder, and increasing usage of biomarker profiling for the disease diagnostics, along with successful completion of the Human Genome Project are the prominent factor driving the growth of the digital PCR system segment in the global PCR technologies market.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North America region is dominating the market throughout the study period. rising prevalence of genetic disorders, and adoption of digital polymerase chain reaction technologies in developing economies such as the US and Canada, and initiatives are taken by leading market players to create awareness is the prime factor contributing to the growth of the market in North America region.
The major companies serving the global polymerase chain reaction (PCR) technologies market are Abbott laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific, Inc., Eppendorf AG,F. Hoffmann-La Roche AG,GE Healthcare, Illumina, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2021, Clinical Enterprise Inc. announced a partnership with Ginkgo Bioworks to support the Operation Expanded Testing Program with the US Department of Health and Human Services and the Department of Defense. Operation Expanded Testing provides fully federally funded COVID-19 PCR testing to K-12public and private schools, historically Black Colleges & Universities, daycare centers, community organizations, congregate settings, correctional facilities, and underserved communities.
The market study of the global polymerase chain reaction (PCR) technologies market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
The Report Covers: